期刊文献+

142例美罗培南临床应用分析 被引量:7

Analysis of 142 Cases of Meropenem in Clinical Applications
下载PDF
导出
摘要 目的:分析我院美罗培南的使用情况,为临床合理用药提供依据。方法:随机抽取我院2011年住院患者中使用美罗培南病例142份,填写调查表,并对结果进行统计分析。结果:142例中合理与基本合理用药占88.73%,不合理用药占11.27%。结论:该院临床上美罗培南的应用基本合理,但也存在无适应证给药、预防给药等不合理用药情况、患者医药费用负担较大,ADR发生率相对较高等问题,应严格执行碳青霉烯类抗菌药物使用的相关规定,提高病原学送检率,减少经验用药,提高药物疗效及合理用药水平。 Objective: To analyse the utilization of meropenem in our hospital, provide the references for clinical rational drug use. Methods : The 142 cases was selected randomly of hospitalized patients in our hospital. The date was filled in the questionnaire, and the results were analyzed. Results: The rationable drug use accounted for 88.73% of the 142 cases. Conclusion: Meropenem is invalid for a variety of therapeutic effect of multiple bacterial infection has a good, and the hospital on the clinical application of meropenem is rea- sonable. But there are also have irrational drug using, such as with larger cost burden in patients. Therefore, we should strictly control the drug using related provision of this class, increaese the rate of pathogenic detection, reduce the experience of drug use, improving the level of rational drug use.
出处 《中国药物评价》 2013年第1期19-21,共3页 Chinese Journal of Drug Evaluation
关键词 美罗培南 药物利用评价 合理应用 Meropenem Drug use evaluation Reasonable use
  • 相关文献

参考文献5

二级参考文献28

共引文献55

同被引文献64

  • 1黄仲义.美罗培南的药理学和临床应用[J].中国新药与临床杂志,2005,24(12):971-973. 被引量:16
  • 2陈颖,杨国才.裸花紫珠抗炎作用及增强免疫功能的实验研究[J].广东微量元素科学,2006,13(8):39-41. 被引量:60
  • 3邵利,韩艳花,王媛,姚爱荣,王昊.脓毒症研究进展[J].人民军医,2007,50(3):171-173. 被引量:8
  • 4孙传兴.临床疾病诊断依据治愈好转标准[M]第2版.北京:人民军医出版社,2006.3-10.
  • 5Angus DC, Linde-Zwirble WT, Lidicker Let al. Epidemiology of severe sepsis inthe United States:analysis of incidence, outcome, and associated costs of care. CritCare Med,2002;29:1303-1310.
  • 6Vincent JL, Sakr Y, Sprung CL, et al. Sepsis in European intensive care units: Results of the SOAP study [J]. Crit Care Med,2006;34(2):344-353.
  • 7Hotchkiss RS,Coopersmith CM, McDurni JE, Ferguson TA. Tilting towardimmunosuppression. Nat Med,2009; 15:496-497.
  • 8Riedemann NC,Guo RF, Ward PA. Novel strategies for the treatment of sepsis. NatMed,2003 ;9:517-524.
  • 9Van der Poll T, Van Deventer SJ. Cytokines and anticytokines in the pathogenesisof sepsis. Infect Dis Clin North Am, 1999; 13:413-426.
  • 10刘长庭,王增武.美罗培南临床应用2732例的疗效评价[J].中华医院感染学杂志,2008,18(2):249-250. 被引量:31

引证文献7

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部